The text reads T1D RELAY a study for those newly diagnsoed with type 1 diabetes. Segments of light blue, dark blue and red lines run diagonally in the background.
Research Spotlight

Newly diagnosed with type 1 diabetes? Help us find out if a novel combination therapy can preserve insulin production

TrialNet’s latest clinical study will test two established immune therapies—rituximab-pvvr followed by abatacept—to see if the combination can preserve insulin production in people recently diagnosed with type 1 diabetes (T1D).

Read more
Subscribe to T1D RELAY Study